Online archive to link tumor scans, genetic data
June 24, 2011 By Michael C. Purdy in Cancer
The Cancer Imaging Archive, created by scientists at Washington University School of Medicine, will make millions of images like this scan of a brain tumor accessible to both researchers and the general public.
The National Cancer Institute (NCI) has chosen Washington University School of Medicine in St. Louis to create an innovative, Internet-accessible database of millions of cancer images.
The Cancer Imaging Archive (TCIA) will combine tumor scans collected from multiple cancer research initiatives into a single searchable database accessible to both research scientists and the general public.
One of the first projects to be included will be The Cancer Genome Atlas, a collaboration to catalog the genetic errors in more than 20 different types of cancers. The universitys Genome Institute has played a leading role in that effort.
For the first time, TCIA will connect the genetic information from the genome atlas project to X-rays and MRI, CT and PET scans used to diagnose patients cancers. The links will make possible new studies of tumors that may improve diagnosis and treatment, says Fred Prior, PhD, director of TCIA at Washington Universitys Mallinckrodt Institute of Radiology.
Linking scans to genetic information may help us to identify aspects of the tumors appearance that can help us determine the genetic type of the tumor, Prior says. That could be extremely important for diagnosis and treatment of some cancers.
As an example, Prior cites glioblastomas, a type of dangerous and difficult-to-treat brain tumor. Genome atlas researchers have identified four distinct genetic signatures in these tumors and plan to use those signatures to customize treatments. If scientists can correlate tumor scans to particular genetic subtypes, it may expedite efforts to improve treatment.
TCIA can also be used by patients and the public, who can search for images of tumors based on the type of scan and the area of the body where the tumor is found. Organizers are making the data publicly accessible for educational and informational purposes. Patients' names and identifying information will not be made public.
Prior is director of the universitys Electronic Radiology Laboratory, where researchers specialize in quality assurance, analysis and management of biomedical imaging data. The laboratorys scientists have been actively working with the National Biomedical Imaging Archive, a software package originally created at the NCI. Prior and his colleagues adapted the package for use in the National Lung Screening Trial, and now they have modified it to build TCIA.
TCIA will support a wide variety of cancer research initiatives by providing scientists with easy access to the enormous amounts of data in the archive, Prior says. This data will also be available to the general public with links to Web pages that help them understand the images.
NCI is providing $800,000 to Washington University during the first year of the TCIA project and additional funding in its second and third years.
The website for TCIA is www.cancerimagingarchive.net . Registration and use of the archive are free.
Provided by
Washington University School of Medicine in St. Louis
-
CT screening reduces lung-cancer deaths in heavy smokers
Nov 19, 2010 |
not rated yet |
0
-
New bowel cancer gene discovery
Nov 10, 2010 |
not rated yet |
0
-
Taking aim at deadliest cancer: Study highlights advances in targeted drug therapy
Nov 10, 2010 |
not rated yet |
0
-
Controlling lung cancer in mice with milk thistle extract
Feb 16, 2011 |
not rated yet |
0
-
Post-treatment PET scans can reassure cervical cancer patients
Nov 20, 2007 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
Why is zone 1 in liver more prone to ischemic injury?
May 23, 2013
-
How can there be villous adenoma in colon, if there are no villi there
May 22, 2013
-
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013
-
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013
-
If you became brain-dead, would you want them to pull the plug?
May 17, 2013
-
MRI bill question
May 15, 2013
- More from Physics Forums - Medical Sciences
More news stories
New fluorescent tools for cancer diagnosis
In recent years, microRNAs (miRNAs) and other non-coding RNAs are small molecules that help control the expression of specific proteins. In recent years they have emerged as disease biomarkers. miRNA profiles have been used ...
Cancer
May 24, 2013 |
not rated yet |
0
Modulating the immune system to combat metastatic cancer
Cancer cells spread and grow by avoiding detection and destruction by the immune system. Stimulation of the immune system can help to eliminate cancer cells; however, there are many factors that cause the immune system to ...
Cancer
May 24, 2013 |
5 / 5 (1) |
0
Scientists put bowel cancer under the microscope
Researchers from London's Kingston University have begun a two-year study which could help prolong the lives of people with colorectal tumours.
Cancer
May 24, 2013 |
5 / 5 (1) |
0
Researcher identifies breast cancer fighting hormone
Transformative research from Western University has identified new hormones in the body which may suppress breast cancer and stimulate the regression of breast tumors.
Cancer
May 24, 2013 |
5 / 5 (2) |
0
Ground breaking cancer research finds immune system link
(Medical Xpress)—Curtin University researchers have found evidence that targeting specific cells in the body can reverse the effects of cancer on the immune system.
Cancer
May 24, 2013 |
5 / 5 (4) |
0
First drug to improve heart failure mortality in over a decade
Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...
Heart failure accelerates male 'menopause'
Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...
Death highest in heart failure patients admitted in January, on Friday, and overnight
Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...
Feds fight morning-after pill age ruling in NY
(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...
Researchers identify first drug targets in childhood genetic tumor disorder
Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...
Driving and hands-free talking lead to spike in errors, study shows
Talking on a hands-free device while behind the wheel can lead to a sharp increase in errors that could imperil other drivers on the road, according to new research from the University of Alberta.